Шляхи ЕСI-MС фрагментації деяких 1,2,4-триазол-3-тіонів, проміжних продуктів при синтезі активних фармацевтичних інгредієнтів

• Main Authors: Varynskyi, Borys O., Kaplaushenko, Andriy G.
• Format: Article
• Language: English
• Published: National University of Pharmacy 2020
• Subjects: mass spectrometry; high performance liquid chromatography; 1; 2; 4-triazole-3-thiones; UDC 547.792; 543.51; мас-спектрометрія; високоефективна рідинна хроматографія; 4-триазол-3-тіони; УДК 547.792; масс-спектрометрия; высокоэффективная жидкостная хроматография; 4-триазол-3-тионы
• Online Access: https://ophcj.nuph.edu.ua/article/view/ophcj.20.177613

Aim. To determine the fragmentation pathways of eight 1,2,4-triazole-3-thiones, which are intermediate products in the synthesis of active pharmaceutical ingredients of potential and registered pharmaceutical formulations.Results and discussion. HPLC-MS analysis of eight 1,2,4-triazole-3-thiones, which are intermediate products in the synthesis of salts of 1,2,4-triazolylthioacetate acids, has been carried out; the mass spectra of the compounds to be analyzed have been registered in ESI-mode with different fragmentor voltage (0, 100, 200 V). The fragmentation pathways and patterns of ion decay for compounds to be analyzed have been proposed.Experimental part. Agilent 1260 Infinity HPLC System with Agilent 6120 mass spectrometer were used. HPLC-MS conditions: column – 4,6 × 30 mm, reversible phase Zorbax SB C18, 1.8 μm, 40 oC; mobile phase – 0.1 % HCOOH in H2O and 0.1 % HCOOH in СH3CN in isocratic mode (50:50, v/v); the flow rate – 0.4 mL/min; ion source – API-ES; positive polarity; drying gas – nitrogen (rate – 10 L/min); the capillary voltage – 4000 V; scanning in the range of m/z 100 – 1000.Conclusions. For the first time it has been interpreted the mass spectra of 1,2,4-triazole-3-thiones series, the intermediate compounds in the synthesis of active pharmaceutical ingredients of pharmaceutical formulations. The fragmentation pathways and patterns of eight 1,2,4-triazole-3-thiones have been shown. Received: 06.09.2019Revised: 20.01.2020Accepted: 27.02.2020